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Diabetes is the main cause of peripheral neuropathy where older patients are at increased risk 31 
of diabetic distal symmetrical polyneuropathy (DSPN) due to age-related nerve degeneration 32 
and vascular changes. The aim of the study was to investigate the effect of resistance training 33 
on nerve conduction, measures of neuropathy and arterial stiffness in older patients with DSPN. 34 
In a randomized controlled trial, thirty-four older adults with type-2 diabetes and peripheral 35 
neuropathy were enrolled and randomly assigned to experimental and control groups. The 36 
experimental group carried out circuit resistance training (1-3 rounds, 11 exercises, 10-15 reps, 37 
50%-60% of 1RM, 3 times per week) for 12 weeks. Measurements were performed at baseline 38 
and 48 h after the intervention. Measures of DSPN including Michigan neuropathy screening 39 
instrument (MNSI), Michigan diabetic neuropathy score (MDNS), motor nerve action potential 40 
amplitude (APA), sensory and motor nerve conduction velocity (NCV) improved following 41 
intervention (p<0.001, p = 0.001, p = 0.034, p = 0.001, and p = 0.001, respectively). Sensory 42 
APA did not change after the intervention (p = 0.139). Cardio-ankle vascular index (CAVI) 43 
and ankle-brachial index (ABI) improved in the experimental group compared with the control 44 
group (p = 0.014 and p = 0.033, respectively). In addition, HbA1C decreased following the 12-45 
week resistance training program (p=0.002). Older adults with DSPN respond positively to 46 
resistance training by improved neuropathy symptoms, nerve conduction, arterial stiffness and 47 
glucose regulation. Resistance training offers a positive intervention that can abate the 48 
progression of DSPN in older adults. 49 
 50 
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1. Introduction 61 
Type 2 diabetes mellitus is associated with progressive neurodegenerative complications. 62 
Diabetic distal symmetrical polyneuropathy (DSPN) is a chronic microvascular complication 63 
of diabetes that can cause symptoms of severe pain and numbness [1]. Metabolic and vascular 64 
factors are known to be the major contributors of the pathogenesis and development of DSPN 65 
[2]. Accordingly, elevated glucose concentration and impaired vascular function is associated 66 
with severe neuropathy [2]. For instance, elevated femoral arterial stiffness has been reported 67 
to be associated with ischemic symptoms in the lower extremity of patients with diabetes [3]. 68 
Increased arterial stiffness in the lower limbs is accompanied by elevated resistance against 69 
blood flow that leads to decreased flow in the limbs arteries [3]. Diabetes related peripheral 70 
neuropathy is especially troublesome in older patients as aging is an independent risk factor for 71 
peripheral neuropathies [4]. Aging is associated with structural and functional changes in the 72 
central and peripheral nervous system [5]. It has been indicated that aging can increase nerve 73 
lipid peroxidation, Schwann cell apoptosis [6], nerve demyelination and axonal degeneration 74 
[7]. Hence, older patients with DSPN are at increased risk of nerve degeneration and related 75 
complications [4]. These changes have a negative impact on activities of daily living and 76 
quality of life and increase the risk of morbidity and mortality in this population [4, 8]. DSPN 77 
is the major cause of foot ulceration and non-traumatic lower limb amputation in diabetes [9]. 78 
Thus, any measures that can lessen the signs and symptoms of the disease would be a welcome 79 
adjuvant intervention. 80 
Currently, there is no definitive treatment for DSPN and the majority of therapies focus 81 
on pain abatement [10]. However, addressing the underlying mechanisms of DSPN including 82 
hyperglycemia and vascular dysfunction can influence the development of the disease [10]. 83 
Optimizing glucose control has been shown to be crucial for preventing and delaying the 84 
development of peripheral nerve damage in type 2 diabetes [11]. In addition, restoring blood 85 
 
 
flow to the lower extremity improves nerve conduction in patients with DSPN [12]. Exercise 86 
training offers a wide range of benefits to patients with type 2 diabetes including optimal 87 
glycemic control, improved vascular function and arterial stiffness [13-15]. Additionally, 88 
physical activity and exercise training are known to have benefits on central and peripheral 89 
nerves function. For example, aerobic training protects peripheral nerves from pathological 90 
changes related to aging [6] and strength training has been shown to increase the thickness of 91 
myelin sheath and delay age-related progressive changes in peripheral nerves [16]. 92 
Evidence shows that exercise has benefits on growth of damaged nerves that is suggested 93 
to be dependent on the type of injury, exercise modality, duration and intensity [17, 18]. 94 
However, there is little consensus on the benefits of different exercise modalities on diabetes-95 
related peripheral nerve damage due to the paucity of research. Aerobic and balance exercises 96 
are frequently studied and suggested modes of exercise for patients with DSPN [19]. Reviews 97 
of literature indicated that resistance training has been recommended for clinical purposes as it 98 
brings about various benefits [14, 15]. For instance, some studies suggested that resistance 99 
training can be more effective than aerobic training for glucose regulation in patients with type 100 
2 diabetes [13]. These benefits can have unique clinical implications in type 2 diabetes and the 101 
related complications. However, to date, no study has evaluated the effect of resistance training 102 
on DSPN in older adults, which might be related to the concerns regarding feasibility and safety 103 
of exercise in this population. Physicians seem to be reluctant to encourage patients with DSPN 104 
to engage in resistance-type exercise, possibly because of fears of adverse outcomes such as 105 
increased pain or foot ulceration. This may have been arisen from preliminary research that 106 
suggested DSPN might be a contraindication for weight-bearing exercise [20]. However, recent 107 
studies indicated that weight-bearing exercise in the form of aerobic and balance exercise do 108 
not increase foot pain and ulcers in individuals with DSPN [21]. Accordingly, the aim of this 109 
investigation was to investigate the effect of supervised low-to-moderate intensity resistance-110 
 
 
type exercise program on neuropathy symptoms, nerve conduction and arterial stiffness in older 111 
adults with DSPN. We hypothesized that engaging in resistance training would have a positive 112 
influence on neuropathic symptoms in older adults with DSPN. 113 
 114 
2. Materials and Methods 115 
A randomized-controlled trial was conducted to assess the effect of a 12-week resistance 116 
training on neuropathy symptoms, nerve conduction and arterial stiffness. The study complied 117 
with the codes of Declaration of Helsinki for human research and approved by the Human 118 
Research Ethics Committee of Shahrood University of Medical Sciences 119 
(IR.SHMU.REC.1398.087, 09.30.2019) and the trial was registered at Iranian Clinical Trial 120 
Registry (Trial No: IRCT20170120032066N4); although the trial appears to be registered 121 
retrospectively, all authors can attest that the trial was registered prior to participant enrolment.  122 
 123 
2.1. Participants 124 
Community-dwelling male patients registered in diabetes clinics and aged > 60 years were 125 
invited to participate and screened for eligibility. The patients were included if they had history 126 
of diabetes > 5 years, HbA1c > 6.6%, inactive lifestyle, and if they were diagnosed with mild 127 
to moderate stage of DSPN. Participants were excluded if they were not permitted to participate 128 
in exercise programs, if they had orthopedic issues, foot deformity and ulcers, and if they had 129 
absent nerve action potential amplitude. The diagnosis of type 2 diabetes was based on the 130 
criteria by American Diabetes Association and the presence of DSPN was confirmed by a 131 
neurologist based on Michigan Diabetic Neuropathy Score (MDNS) and Michigan Neuropathy 132 
Screening Instrument (MNSI) with signs and symptoms of DSPN [22, 23]. Physical activity 133 
level was assessed by The International Physical Activity Questionnaire (IPAQ) and all the 134 
 
 
participants were leading inactive lifestyle. Eligibility was confirmed in 34 volunteers (Figure 135 
1), they were informed about the study procedure and provided written consent.  136 
 137 
2.2. Randomization 138 
The randomization was carried out by a person independent of the trial team to ensure 139 
concealment of the allocation. The participants were assigned to the groups using a blocked/ 140 
stratified randomization method in a 1:1 ratio. Stratification was applied based on the stage of 141 
DSPN at two levels including mild and medium neuropathy. A distinct block randomization 142 
with the block size of 4-6 was implemented for each stratum. The participants were randomly 143 
assigned to each group using random number tables generated by computer. 144 
 145 
2.3. Exercise Training 146 
According to exercise guidelines, type 2 diabetic patients have been recommended to engage 147 
in resistance training programs with moderate intensity of ≥ 50% of 1RM at least 2 times a 148 
week on non-consecutive days [24]. Given this and previous pilot studies in this population, 149 
the resistance training protocol began at the least recommended exercise intensity and preceded 150 
by a familiarization period.  The experimental group was familiarized with the exercise protocol 151 
over two weeks. One-repetition maximum (1RM) was estimated by each participant 152 
performing 10-RM for each exercise. This was re-assessed every month to adjust the resistance 153 
for each exercise in order to ensure progressive overload. The resistance exercise program was 154 
performed 3 times per week, for 12 weeks that lasted ~90 minutes per session and consisted of 155 
11 dynamic exercises on large muscle groups with free weights and machines including squat, 156 
bench press, shoulder press, knee extension, knee flexion, calf rise, elbow extension and 157 
flexion, sit ups, lat pulldown and back extension. The resistance training consisted of 1-3 158 
circuits with 10-15 reps for each exercise at between 50-60% of 1RM. Rest intervals of 30-60 159 
 
 
s between each exercise and 3-5 min between each round were allowed. A 15-minute warm up 160 
and 10-minute cool down consisting of brisk walking/ jogging, stretching of major muscle 161 
groups and the main exercises with lighter weights were included at each session.  162 
All exercise sessions were carried out under the supervision of an exercise physiologist. 163 
To avoid any possible hyper/hypoglycemia induced by exercise, blood glucose levels were 164 
checked prior to each exercise session to ensure participants were in a safe range (not to be < 165 
100 mg/dl or > 250 mg/dl). If glucose testing revealed hyperglycemia, exercise training was 166 
postponed and if hypoglycemic, a carbohydrate snack was provided and glucose was re-167 
checked. Furthermore, to avoid DSPN-related adverse events such as pain aggravation and foot 168 
ulceration, the participants were asked to be wearing comfortable and dry socks and shoes 169 
while exercising.  170 
Participants were required to follow their habitual diet throughout the study. During the 171 
familiarization period and during the last week of training, the calorie intake was recorded by 172 
a 3-day dietary recall. Dietary data were recorded in the case of significant difference between 173 
groups and/ or between pre and post-test and hence requiring the application of a covariate of 174 
analysis. In addition, food intake before baseline measurements was recorded using a 24-hour 175 
recall and participants were asked to replicate the same diet before the final measurements to 176 
the best of their ability. 177 
 178 
2.4. Measurements 179 
In line with our hypothesis the primary outcomes were MDNS, Sural sensory and Peroneal 180 
motor NCV and action potential amplitude, CAVI and ABI.  All measurements were carried 181 
out at baseline and were replicated 48 h following last exercise session. The participants were 182 
asked to abstain from vigorous physical activity and caffeine for 24 h before the measurements. 183 
Body composition was analyzed by a bioelectrical impedance analyzer (Inbody230, Korea) 184 
 
 
after an overnight fast. Fasting blood samples were taken from the antecubital vein and used to 185 
assess HbA1c content by liquid chromatography (Pishtaz, Tehran, Iran).  Arterial stiffness was 186 
measured by oscillometric method using VaSera VS-2000 (Fukuda Denshi, Tokyo, Japan) that 187 
captures pulse waves in 4 limbs non-invasively. Before measurements, participants 188 
comfortably rested supine for 10 minutes. The measurements were carried out according to the 189 
manufacturer's instruction. Blood pressure cuffs with sensors were applied to all limbs to 190 
generate plethysmograms. Phonocardiogram (PCG) was also placed at sternal angel and ECG 191 
leads were attached to the arm. The measurements of brachial and ankles systolic pressure and 192 
calculations of CAVI and ABI were automatically carried out by the Vasera-2000 system [25]. 193 
Nerve conduction studies and neuropathy assessments were performed by a neurologist blinded 194 
to group allocations using an EMG/NCV system (Viking Quest, USA). For sural sensory nerve 195 
the recording point was behind the lateral malleolus and stimulation point was 14 cm from the 196 
active electrode up to the posterior aspect of the calf. For peroneal motor nerve recording point 197 
was at extensor digitorum brevis muscle and stimulation points were at anterior ankle and 198 
lateral popliteal fossa immediately below the head of fibula. For both nerves studied nerve 199 
action potential amplitude (APA) and nerve conduction velocity (NCV) have been reported. 200 
The measurements were performed in a quiet room with constant temperature 25 ± 2 °C. 201 
Michigan Diabetic Neuropathy Instrument (MNSI) consists of 15 questions with yes/no 202 
responses on foot sensation that indicates the presence and severity of symptoms of neuropathy 203 
[22]. Michigan Diabetic Neuropathy Score (MDNS) consists of  46-point score of clinical 204 
neurological examination [22].  205 
 206 
2.5. Statistical analysis 207 
The sample size was determined through a priori power analysis for repeated measures 208 
ANOVA using G*power (version 3.1.9.2). The calcualtion was based on a medium effect size 209 
 
 
(= 0.06) for interaction between time and group, α = 0.05, and power of 80% [26]. Based on a 210 
previous study, the correlation between repeated measures was assumed to be 0.6 for nerve 211 
conduction velocity [27]. According to these assumptions a sample size of 28 was required. 212 
Considering a drop-out rate of 20%, the initial number of participants included in this study 213 
was 34. 214 
Data were expressed as mean ± SD. The Shapiro-Wilk test was used to confirm the 215 
normal distribution of the data. The effects of exercise training on variables were determined 216 
by repeated measures of ANOVA (Time x Group) and main effects of time were also reported. 217 
For follow-up comparisons, Bonferroni's post-hoc analysis was carried out. An independent 218 
samples t-test was also used to examine the change scores between groups over time (pre to 219 
post-test). Effect sizes of the differences was indicated by partial eta squared. Pearson's 220 
correlation coefficient was used to determine the association between variables. The 221 
significance level was P < 0.05. Data were analyzed using SPSS for windows version 25 (SPSS 222 
Inc, Chicago, III). 223 
 224 
3. Results 225 
A total of 34 participants were recruited to start the study and were randomized to two groups 226 
(Figure 1). In total, 29 participants completed the study; 2 participants in the experimental 227 
group and 3 participants in the control group failed to complete the study (Figure 1). The 228 
participants' attendance to exercise sessions in the experimental group was 91-100%. The mean 229 
and standard deviation for age, weight, fat percentage, and daily calorie intake are presented in 230 
Table 1. There were no significant differences between groups at baseline (p > 0.05). Mean 231 
and standard deviation for other variables are presented in Table 2. The baseline values were 232 
similar in both groups (P > 0.05).  233 
 
 
The supervised resistance training program was well tolerated with no adverse events 234 
related to exercise program other than the expected transient muscle soreness during first few 235 
sessions. The main intervention commenced with a familiarization period at lower intensity 236 
and glucose level was strictly checked prior to exercise sessions, as previously described. As a 237 
result, no adverse event including exercise-induced hypoglycemia/ hyperglycemia was 238 
observed and the participants were able to deal with the procedure. Moreover, no adverse 239 
events related to DSPN such as aggravated pain and foot ulceration were reported throughout 240 
the study. 241 
Data analysis indicated time x group interaction (F = 4.996, p = 0.034, ηp2 = 0.156) and 242 
main effect of time (F = 8.725, p = 0.006, ηp2 = 0.244) for motor nerve action potential 243 
amplitude (APA). Analysis of change scores between groups using independent samples t-test 244 
also revealed a significant difference (p = 0.034). Follow-up comparison indicated an increase 245 
of motor nerve APA in the experimental group (6% increase, p = 0.048). However, the time x 246 
group interaction for sensory APA was not significant (F = 2.329, p = 0.139, ηp2 = 0.079) and 247 
analysis of change scores  between groups using independent samples t-test also indicated no 248 
significant difference (p = 0.139). A difference in motor NCV was observed with the time x 249 
group interaction (F = 13.456, p = 0.001, ηp2 = 0.333) and main effect of time (F = 11.153, p = 250 
0.002, ηp2 = 0.292), (Figure 2). Analysis of change scores between groups using independent 251 
samples t-test also indicated a significant difference (p = 0.001). Follow-up comparison 252 
indicated an increase of motor NCV in the experimental group (7% increase, p = 0.016). For 253 
sensory NCV, there was also a time x group interaction (F = 14.242, p = 0.001, ηp2 = 0.345) 254 
and main effect of time (F = 26.217, p = 0.0001, ηp2 = 0.493). Analysis of change scores  255 
between groups using independent samples t-test also revealed a significant difference (p = 256 
0.001). Follow-up comparison indicated an improvement of sensory NCV in the experimental 257 
group (8% increase, p = 0.002). Furthermore, time x group interaction (F = 12.541, p = 0.001, 258 
 
 
ηp2 = 0.317) and main effect of time (F = 8.893, p = 0.006, ηp2 = 0.248) were observed for 259 
MDNS and analysis of change scores between groups using independent samples t-test also 260 
revealed a significant difference (p = 0.001). Follow-up comparison revealed a reduction for 261 
MDNS in the experimental group (10% reduction, p = 0.019). We also observed a time x group 262 
interaction (F = 26.350, p = 0.0001, ηp2 = 0.494) and main effect of time (F = 7.640, p = 0.010, 263 
ηp2 = 0.221) for MNSI (Figure 2). Analysis of change scores between groups using independent 264 
samples t-test also revealed a significant difference (p = 0.0001) Follow-up comparison 265 
indicated a marked reduction of MNSI in the experimental group (20% improvement, p = 266 
0.003). Pearson's correlation coefficient analysis indicated the changes in MNSI score was 267 
associated with the changes in HbA1C (r = 0.589, p = 0.021). The correlation of MNSI with 268 
ABI and sensory nerve conduction did not reach significance (r = -0.447, p = 0.095 and r = -269 
0.473, p = 0.075, respectively). 270 
A difference in CAVI was observed with the time x group interaction (F = 6.904, p = 271 
0.014, ηp2 = 0.204) and main effect of time (F = 12.703, p = 0.001, ηp2 = 0.320), (Figure 2). 272 
Analysis of change scores between groups using independent samples t-test also revealed a 273 
significant difference (p = 0.001). Follow-up comparison revealed a reduction in the 274 
experimental group (6.6% reduction, p = 0.039). For ABI, there was a time x group interaction 275 
(F = 5.077, p = 0.033, ηp2 = 0.158) but the main effect of time was not significant (F = 2.683, 276 
p = 0.113, ηp2 = 0.090). Analysis of change scores  between groups using independent samples 277 
t-test also revealed a significant difference (p = 0.033). Follow-up comparison did not show 278 
significant alterations in the experimental group (4% increase, p = 0.123). A difference in ankle 279 
systolic pressure was observed with the time x group interaction (F = 8.670, p = 0.007, ηp2 = 280 
0.243) and main effect of time (F = 4.258, p = 0.049, ηp2 = 0.136). Analysis of change scores 281 
between groups using independent samples t-test also revealed a significant difference (p = 282 
0.007). Follow-up comparison revealed an increase in the experimental group (3.4% increase, 283 
 
 
p = 0.001). For brachial systolic pressure, there was neither significant time x group interaction 284 
(F = 0.867, p = 0.360, ηp2 = 0.031) nor the main effect of time (F = 1.000, p = 0.326, ηp2 = 285 
0.036).  286 
We also observed a time x group interaction (F = 11.240, p = 0.002, ηp2 = 0.294) and 287 
main effect of time (F = 5.712, p = 0.024, ηp2 = 0.175) for HbA1C (Figure 2). Analysis of 288 
change scores between groups using independent samples t-test also revealed a significant 289 
difference (p = 0.002). Follow-up comparison revealed a reduction in HbA1C in the 290 
experimental group (10% reduction, p = 0.025). 291 
 292 
4. Discussion 293 
The aim of the study was to investigate the effect of resistance training on symptoms of 294 
neuropathy, nerve conduction and arterial stiffness in older adults with DSPN. For the first 295 
time, we observed that low-to-moderate intensity resistance training improved measurements 296 
of DSPN including neuropathic symptoms, nerve conduction velocity, nerve action potential 297 
amplitude, measurements of arterial stiffness including CAVI and ABI, and HbA1c levels in 298 
older adults with DSPN. Besides, no major complications and adverse events directly related 299 
to exercise training were reported throughout the intervention. Accordingly, low-to-moderate 300 
intensity resistance training can be an effective and safe therapeutic intervention for this group 301 
of patients.  302 
Nerve conduction velocity and nerve APA improved following 12-week resistance 303 
exercise regimen in older adults with DSPN. This finding is partly in accordance with some 304 
previous studies that reported enhanced NCV of sensory and motor nerves following aerobic 305 
exercise training [26, 27]. The evidence showed that the neural system responds positively to 306 
physical activity through morphological and functional adaptations to the training stimulus [6, 307 
28-30]. Exercise training has been shown to decrease apoptosis of Schwann cells and increase 308 
 
 
myelin thickening [6], increase Schwann cell proliferation [28], enhance axonal regeneration 309 
of the peroneal nerve [30] and improve axon transport and electrophysiological properties [29]. 310 
Resistance training also enhances neural activation and neuroplasticity that occurs at earlier 311 
stages of training program. These changes likely explain the initial functional adaptations and 312 
subsequent strength gains following resistance training program [31]. Moreover, resistance 313 
exercise can activate the effects of neurotrophin because it can increase brain-derived 314 
neurotrophic factor (BDNF) expression and its receptor tropomyosin receptor kinase B (trkB) 315 
[32]. BDNF and its receptor seem to be substantial modulator for axon regeneration as the 316 
continuous presence of BDNF enhanced axon regeneration after nerve damage [33].  317 
The improvements in the measurements of nerve conduction in the current study might 318 
be partly explained by local and direct impact of resistance training on peripheral nerves. 319 
Morphological changes in peripheral nerves are not the only factor to explain nerve conduction 320 
improvements [34]; functional alterations are also essential so that improved neural function 321 
can be attributed to the reinforcement of existing sensory-motor pathways rather than 322 
generating additional pathways [35]. In the present study, the changes in NCV and APA were 323 
coupled with improved neuropathy symptoms. Another established effect of exercise, 324 
irrespective of type, is hypoalgesia induced by exercise [34]. Groover et al, (2013) indicated 325 
that exercise can regulate cutaneous sensation and nociceptive threshold related to prediabetes 326 
[36]. It may be explained by cutaneous regeneration as exercise training has been shown to 327 
increase distal leg intraepidermal nerve fiber density (IENFD) in diabetic patients with [37] 328 
and without neuropathy [38]. Although IENDF is a measure of integrity of small diameter 329 
axons and evaluates unmyelinated axons, it is correlated with large myelinated fiber surrogates 330 
such as nerve conduction studies [38]. Singleton et al, (2014) indicated that development of 331 
abnormal neurological examinations was remarkably reduced in patients receiving exercise 332 
intervention [38]. Additionally, exercise training increased the endogenous opioid production 333 
 
 
which might play a role in neuropathic pain reversal induced by exercise [39]. These alterations 334 
suggest that exercise training provides benefits to both central and peripheral nervous system. 335 
These exercise effects are valuable for this population and we contend that the low-to-moderate 336 
intensity resistance exercise program in this study also has the potential to improve neural 337 
function in older adults with DSPN, which is manifested by reduced neuropathy symptoms. 338 
Besides neural alterations, glucose regulation and vascular function are essential 339 
contributors of nerve function in DSPN. Hyperglycemia is the principal determinant of the 340 
development of DSPN. It has been suggested that 1% increase in HbA1C is associated with 341 
almost 10-15% increase in frequency of DSPN [40]. Constant or fluctuating hyperglycemia 342 
can induce sorbitol accumulation in nerves, oxidative stress, chronic inflammation and 343 
endothelial dysfunction [2] and lead to peripheral nerve damage in type 2 diabetes. Hence, 344 
aggressive control of glucose is crucial for type 2 diabetes and related complications, especially 345 
DSPN. Optimized glucose control reduces nerve conduction abnormalities and is important in 346 
the prevention and treatment of DSPN [41]. We observed a marked reduction in HbA1C from 347 
9.09% to 8.11%  following a 12 week resistance exercise program that was correlated with 348 
alterations in neuropathy symptoms, which supported previous work showing that 349 
improvement in signs of DSPN were coupled with a reduction of HbA1C [37]. The effect of 350 
different modes of exercise on glucose regulation is well documented [15] and resistance 351 
training has been suggested to be as effective as aerobic training to reduce levels of HbA1C 352 
[15]. One study has shown that resistance training was superior at reducing HbA1C level to 353 
aerobic training [13]. Hence, the application of resistance training can be clinically significant 354 
because of the HbA1C lowering effects, the potential to lower the prevalence and progression 355 
of DSPN [31]. 356 
DSPN has been shown to be significantly associated with blood flow to the peripheral 357 
nerves and arterial stiffness [3, 42]. Increased arterial stiffness in the lower extremity can 358 
 
 
compromise blood flow to foot arteries [3]; this has been shown with femoral arterial stiffness 359 
in diabetes patients being closely related with ischemic symptoms of the lower extremity. 360 
Reduced endoneural blood flow causes hypoxia in the peripheral nerves that can influence 361 
nerve conduction [2]. For instance, NCV is shown to be sensitive to blood supply, and so the 362 
restoration of blood flow to the lower extremity can enhance conduction velocity of peroneal 363 
nerve in patients with type 2 diabetes [12]. This study showed a reduction in the mean values 364 
of CAVI and an increase in ABI following the 12-week resistance training intervention. A 365 
recent systematic review concluded that resistance training at lower intensities could bring 366 
about cardiovascular health benefits and may improve measures of arterial stiffness [42]. CAVI 367 
reflects heart-to-ankle stiffness of arterial walls and ABI is the ankle-brachial pressure index 368 
reflecting the degree of arterial blockage in the lower limbs that is reduced in peripheral arterial 369 
diseases. Despite the non-significant alterations in brachial systolic pressure, ankle pressure 370 
did improve following resistance training. Thus, improvements in ABI are thought to be driven 371 
by an improvement in ankle systolic pressure rather than changes in brachial systolic pressure. 372 
A potential explanation for improved ankle pressure and ABI by resistance training might be 373 
improved blood flow in the lower extremities [43]. Exercise training enhances endothelium-374 
dependent and independent vasodilation, nitric oxide synthesis and bioavailability and 375 
expression of growth factors that can lead to improved blood flow to the limbs [44]. Even 376 
though leg vascular function can be precisely assessed via ultrasound or femoral-ankle pulse 377 
wave velocity, ABI has also a well-supported prognostic value that reflects improved leg 378 
vascular function following resistance training in this study. Regarding this, Fahs et al. (2011) 379 
reported that acute resistance exercise increased arterial compliance and calf blood flow. They 380 
found that high-intensity resistance exercise at 70% of 1RM caused greater elevation of calf 381 
vascular conductance, elasticity of large artery and small artery compared to low intensity 382 
exercise at 20% of 1RM  [14]. Hence, high-intensity resistance exercise could be more effective 383 
 
 
than low-intensity exercise to improve large and small artery blood flow. The exercise intensity 384 
in our study roughly corresponded to the high-intensity protocol implemented by Fahs et al. 385 
(2011). Muscle contraction during resistance exercise causes hyperemia that can immediately 386 
increase arterial compliance and blood perfusion to the active sites. Over time, with repeated 387 
exposure, exercise-induced elevation of blood flow can increase blood supply to the vasa 388 
nervorum and therefore contribute to restoring nerve function [46]. Besides, resistance exercise 389 
reduces systemic vascular resistance indicating relaxation of vascular smooth muscle. This can 390 
further explain improved arterial compliance and blood flow by resistance exercise training 391 
[14]. Hence, improved measurements of nerve conduction in this study could also be attributed 392 
to factors other than glucose regulation alone i.e., restoration of blood flow and oxygen supply 393 
to peripheral nerves as a result of resistance training. However, due to little understandings in 394 
this area it needs to be clarified in future studies. 395 
In contrast, some previous studies did not report the effectiveness of an aerobic exercise 396 
program on some measurements of nerve conduction in DSPN [25, 37]. Dixit et al, (2014) 397 
reported that aerobic training over 8 weeks had no significant effect on nerve APA of the 398 
peroneal nerve in patients with DSPN [26]. This discrepancy might be explained by the 399 
exercise type (aerobic versus resistant-type training), the intensity and duration and hence 400 
determine nerve response to training. Exercise has been suggested to be an effective treatment 401 
for nerve functional recovery, yet the effects depend on the type, duration and intensity of the 402 
protocol [17]. Another possible mediator in the response to exercise is sex; where a previous 403 
animal study reported that the effect of different exercises on axon regeneration after peripheral 404 
nerve injury is sex-dependent [47]. This study showed that male animals were more responsive 405 
to continuous exercise while female animals responded well to interval exercise [47]. This 406 
observation might go some way to explaining the differences in studies where a male-only 407 
cohort was used. Based on the contribution of sex on nerve responsiveness to exercise [47], the 408 
 
 
mediatory effects of resistance training to this intervention could be explored in future studies 409 
can extend the understandings in this area.  410 
 411 
5. Limitations and Future Directions 412 
The study includes some strength and limitations to be acknowledged. In spite of several 413 
medical concerns with this group of patients, the adherence to exercise intervention was very 414 
good and drop-out rate was trivial. Furthermore, walking and jogging is the frequently used 415 
and prescribed form of exercise in this population. This is the first randomized trial that 416 
indicates feasibility of resistance-type exercise program for older adults with DSPN. The 417 
homogenous group of male participants show the benefits of resistance training for this cohort. 418 
However, the data might be limited to this cohort and further studies on female participants 419 
should be conducted to increase our understanding regarding effect of sex on exercise-induced 420 
neural changes in DSPN and extend the generalizability of the findings.  421 
We observed benefits of resistance training on neuropathic symptoms in older male 422 
adults with DSPN. Since diabetes-related nerve damage is associated with impaired balance 423 
and increased risk of falling [48], further research is required to determined how the effects of 424 
resistance training can translate into functional measures such as daily physical activities and 425 
quality of life. A greater understanding of the effects of resistance-type exercise on functional 426 
measurements can provide further implications for exercise recommendations to this 427 
population. One might assume that improved nerve conduction measurements and symptoms 428 
of neuropathy can be resulted from the concurrent effect of resistance training on metabolic 429 
and vascular measures in addition to direct local effects on peripheral nerves. However, due to 430 





6. Conclusions/ Implications 434 
This study provide new data that older patients with DSPN respond positively to low-to-435 
moderate intensity resistance training by improved neuropathy symptoms, nerve conduction, 436 
arterial stiffness and glucose regulation. What is important to note is that resistance-type 437 
training is a safe and feasible intervention to improve the signs and symptoms associated with 438 
the progression of DSPN and hence can be used as an effective intervention to improve these 439 
variables. These new data can be used as a platform for the exploration of other benefits of this 440 
type of intervention, but critically, can be applied in patients with type 2 diabetes and 441 
specifically to the growing population of older adults with diabetic peripheral neuropathy. 442 
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Table 1. Mean ± SD values for age, height, weight, fat percentage, calorie intake, and selected lower and upper-601 
body strength. 602 
Group 
Variable 
Experimental (n=15) Control (n=14) 
Pre Post Pre Post 
Age (years) 63 ± 3 - 64 ± 3 - 
Height (cm) 170.2 ± 5.1 - 168.7 ± 4.0 - 
Weight (kg) 74.9±9.0 73.5±9.0 72.6±8.9 73.2±8.6 
Fat (%) 27.7±4.4 26.6±4.5 26.6±5.1 27.0±4.8 
Calorie intake (Kcal) 2199±267 2216±255 2272±263 2308±221 
Squat 1RM (kg) 56.7±11.0 65.4±9.7 - - 


































Table 2. Description of the changes in mean and standard deviation for variables at baseline and following 634 
12 weeks in groups. 635 
Group Experimental (Mean ± SD, 95% CI) 
 (n=15) 





Pre Post Pre Post 
HbA1C (%) 9.09±1.82 (8.08–10.10) 8.11±1.45 (7.31–8.33) 9.97±1.82 (8.91–11.02) 10.13±1.50 (9.26–11.00) 0.002 0.294 
HbA1C (mmol/ mol) 75.86±19.79(64.90-86.82) 65.13±15.72(56.42-73.4) 85.28±19.61(73.95-96.61) 87.29±16.55(77.72-96.84) 0.002 0.309 
CAVI 8.51±0.73 (8.10–8.92) 7.94±0.69 (7.56–8.34) 8.30±0.52 (7.99–8.60) 8.21±0.48 (7.93–8.49) 0.014 0.204 
ABI 0.94±0.12 (0.87–1.01) 0.98±0.10 (0.92–1.04) 0.95±0.08 (0.90–0.99) 0.94±0.08 (0.89–0.99) 0.033 0.158 
BSP 137.60±10.90(131.55–143.64) 135.80±8.28(131.21–140.28) 138.35±9.06(133.12–143.59) 138.28±6.46(134.55–142.01) 0.360 0.031 
ASP 128.86±9.90(123.38–134.35) 133.33±9.64(127.99–138.67) 131.57±9.04(126.34–136.79) 130.78±9.25(125.44–136.13) 0.007 0.243 
Sensory APA (μV) 4.54±2.06 (3.49–5.69) 4.63±2.05 (3.50–5.77) 4.67±2.01 (3.51–5.83) 4.64±1.99 (3.48–5.79) 0.139 0.079 
Motor APA (mV) 2.92±1.16 (2.27–3.57) 3.12±1.15 (2.48–3.76) 2.95±1.33 (2.18–3.72) 2.98±1.29 (2.23–3.73) 0.034 0.156 
Sensory NCV (m/s) 27.62±8.75 (22.77-32.47) 30.06±8.56 (25.31–34.80) 28.56±8.92 (23.41–33.71) 28.93±8.69 (23.91–33.95) 0.001 0.345 
Motor NCV (m/s) 33.01±8.88 (28.09–37.92) 35.38±8.72 (30.55–40.21) 36.02±9.41 (30.58–41.45) 35.90±8.97 (30.72–41.09) 0.001 0.333 
MDNS 16.53±6.18 (13.11–19.96) 14.87±5.95 (11.57–18.16) 15.36±5.73 (12.05–18.67) 15.50±5.58 (12.28–18.72) 0.001 0.317 
MNSI 8.26±1.94 (7.18 – 9.34) 6.60±1.40 (5.82-7.37) 7.50±2.06 (6.30-8.69) 8.00±1.79 (7.01-8.98) 0.0001 0.494 
Abbreviations: EF, Effect size; CAVI, Cardio-ankle vascular index; ABI, Ankle-brachial index; BSP, Brachial 636 
systolic pressure; ASP, Ankle systolic pressure; APA, Action potential amplitude; NCV, Nerve conduction 637 
velocity; MDNS, Michigan diabetic neuropathy score; MNSI, Michigan neuropathy screening instrument. 638 














































Figure 1. Consort flow chart of participant enrolment, randomization and analysis 683 
 684 
  685 
Adults with T2DM were screened based on 
medical records (n=93) 
Assessment for eligibility (n=48) 
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- Did not meet the inclusion criteria (n=9) 
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Withdrawal (declined to attend the 
lab, n=3) 
 
Completed (n= 14) 
Experimental 
Withdrawal (not related to study, n=2) 
 
 





Figure 2. Changes in A) Motor Nerve Conduction Velocity (NCV); HbA1C; C) Cardio-Ankle 688 
Vascular Index (CAVI); and D) Michigan Diabetic Neuropathy Instrument (MNSI) score from 689 
pre to post-test. The data are presented as Mean ± SD. * Significant difference with 690 
corresponding pre-test values P < 0.05. # Significant Time x Group interaction at P < 0.05.         691 
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